Chlamydia pneumoniae in atherosclerosis

被引：42
|
作者：
Saikku, P [1 ]
机构：
[1] Natl Publ Hlth Inst, KTL, Dept Oulu, Oulu, Finland
来源：
JOURNAL OF INTERNAL MEDICINE | 2000年 / 247卷 / 03期
关键词：
atherosclerosis; Chlamydia pneumoniae; infection; pathogenesis;
D O I：
10.1046/j.1365-2796.2000.00659.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Chlamydia pneumoniae is currently the infectious agent most often associated with the inflammation found in atherosclerosis. The seroepidemiological association and the actual presence of pathogen in lesions has been confirmed in numerous studies, in which technical difficulties seem to be the only limitation. Besides animal experiments and intervention trials, we need information of possible pathogenic mechanisms. Recently, several studies have suggested mechanisms by which C. pneumoniae infection could participate in the development of atherosclerosis.
引用
收藏
页码：391 / 396
页数：6
相关论文
共 50 条
  • [41] Atherosclerosis - A chronic infectious disease caused by Chlamydia pneumoniae [Arteriosklerose - Eine chronische infektionskrankheit durch Chlamydia pneumoniae]
    Stille W.
    Stephan C.
    Gefässchirurgie, 1999, 4 (4) : 185 - 193
  • [42] Ectasia and severe atherosclerosis -: Relationships with Chlamydia pneumoniae, Helicobacter pylori, and inflammatory markers
    Adiloglu, AK
    Can, R
    Nazli, C
    Ocal, A
    Ergene, O
    Tinaz, G
    Kisioglu, N
    TEXAS HEART INSTITUTE JOURNAL, 2005, 32 (01) : 21 - 27
  • [43] Delivery of Chlamydia pneumoniae to the vessel wall aggravates atherosclerosis in LDLr-/- mice
    Hauer, AD
    de Vos, P
    Peterse, N
    ten Cate, H
    van Berkel, TJC
    Stassen, FRM
    Kuiper, J
    CARDIOVASCULAR RESEARCH, 2006, 69 (01) : 280 - 288
  • [44] Serological evidence of Chlamydia pneumoniae lipopolysaccharide antibodies in atherosclerosis of various vascular regions
    Körner, I
    Blatz, R
    Wittig, I
    Pfeiffer, D
    Rühlmann, C
    VASA-JOURNAL OF VASCULAR DISEASES, 1999, 28 (04): : 259 - 263
  • [45] Atherosclerosis in dialysis patients:: does Chlamydia pneumoniae infection contribute to cardiovascular damage?
    Zoccali, C
    Mallamaci, F
    Tripepi, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 : 25 - 28
  • [46] Role of Chlamydia pneumoniae-infected macrophages in atherosclerosis developments of the carotid artery
    Kuroda, S
    Kobayashi, T
    Ishii, N
    Ikeda, J
    Shinohe, Y
    Houkin, K
    Iwasaki, Y
    Nagashima, K
    NEUROPATHOLOGY, 2003, 23 (01) : 1 - 8
  • [47] Part of Chlamydia pneumoniae in atherosclerosis and exacerbation of chronic obstructive pulmonary disease and asthma
    Azzouzi, N
    Elhataoui, M
    Bakhatar, A
    Takourt, B
    Benslimane, A
    ANNALES DE BIOLOGIE CLINIQUE, 2005, 63 (02) : 179 - 184
  • [48] Asymptomatic carotid atherosclerosis is associated with circulating Chlamydia pneumoniae DNA in younger normotensive subjects in a general population survey
    Mitusch, R
    Luedemann, J
    Wood, WG
    Berger, K
    Schminke, U
    Suter, M
    Kessler, C
    John, U
    Rupp, J
    Kentsch, M
    Maass, M
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (02) : 386 - 391
  • [49] Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity
    Sander, D
    Winbeck, K
    Klingelhöfer, J
    Etgen, T
    Conrad, B
    CIRCULATION, 2002, 106 (19) : 2428 - 2433
  • [50] Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis
    Davidson, M
    Kuo, CC
    Middaugh, JP
    Campbell, LA
    Wang, SP
    Newman, WP
    Finley, JC
    Grayston, JT
    CIRCULATION, 1998, 98 (07) : 628 - 633
12345